Moloney Securities Asset Management, LLC Bristol Myers Squibb CO Transaction History
Moloney Securities Asset Management, LLC
- $787 Million
- Q3 2025
A detailed history of Moloney Securities Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 18,027 shares of BMY stock, worth $843,843. This represents 0.1% of its overall portfolio holdings.
Number of Shares
18,027
Previous 16,016
12.56%
Holding current value
$843,843
Previous $741,000
9.72%
% of portfolio
0.1%
Previous 0.1%
Shares
33 transactions
Others Institutions Holding BMY
# of Institutions
2,709Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...